Oncovir
Major Drugs - Washington, DC, US
Oncovir Employees
Oncovir Senior Management
Oncovir Details
Oncovir, Inc is a pharmaceutical corporation dedicated to the development of nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders.We promote Hiltonol® (poly-ICLC) as an experimental viral mimic and broad activator of innate and adaptive immunity. While initially developed as an interferon inducer, Hiltonol® has much broader biological effects in humans, including specific antiviral, immune activating, vaccine adjuvant, and antitumor actions.
Website:
oncovir.com
Employees:
5 - 9
HQ:
202-342-1726
Location:
Washington, DC, US
Revenue:
10 - 20 Million
Oncovir Technologies
Email Providers
Gmail
CMS
Wix
Other
Mobile Friendly
Hosting
Google Cloud Hosting